Author: Admin Fintech

RCI BANQUE: ISSUANCE OF EUR 400 MILLION PERPETUAL NON-CALL 5.5yr INAUGURAL ADDITIONAL Tier 1 NOTES

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) — EQ Fund Solutions (EQ), a leading provider of ownership intelligence, transfer agency, activist and proxy advisory services, announced a strategic partnership with Pristine Advisers, a global investor relations, public relations, and marketing firm. Together, the two firms will deliver comprehensive support to companies and funds — particularly…

Lydiam Group’s rebrand introduces a redesigned website and a modern visual identity to support global growth. It reflects the firm’s regulatory strength, VASP acquisition in Poland, and upcoming market entries in Asia and LATAM underscoring its ambition to rival traditional banks with fintech agility.

London, Sept. 17, 2025 (GLOBE NEWSWIRE) — BNVT Capital today announced the launch of its debut $150M fund to invest in AI-first and technology-driven companies solving humanity’s most pressing challenges.

DALLAS, Sept. 17, 2025 (GLOBE NEWSWIRE) — On September 16, 2025, the Board of Directors of North Dallas Bank & Trust Co. (OTCBB: NODB) declared a regular dividend of $0.10 per share, payable to shareholders of record as of October 17, 2025, with said dividend payable on October 24, 2025.

Gardiner & Theobald strengthens relationship between US and UK businesses, creating a unified global business to drive growth, backed by Hennick & Company.

SP Funds rang The Opening Bell® for the second time at the New York Stock Exchange on December 22, 2023. CEO of SP Funds, Naushad Virji was accompanied by senior management and executives of SP Funds.

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) — MAGACOIN FINANCE, an Ethereum-based cryptocurrency project, today announced it has raised over $14 million in its presale with more than 13,500 investors participating. The achievement comes as Solana-focused market observers begin including MAGACOIN FINANCE in emerging altcoin comparisons, highlighting its growing recognition.

VANCOUVER, British Columbia, Sept. 16, 2025 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company”), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that Eric A. Adams, InMed’s CEO, will present live at the Life Sciences Virtual…

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com